Last update 26 Jul 2025

Tinzaparin Sodium

Overview

Basic Info

Drug Type
Polymer
Synonyms
Logiparin, Tinzaparin sodium (USAN), DMP-702
+ [4]
Target
Action
activators
Mechanism
AT III activators(Antithrombin-III activators)
Therapeutic Areas
Active Indication
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Canada (31 Dec 1994),
Regulation-
Login to view timeline

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pulmonary Embolism
United States
14 Jul 2000
Venous Thrombosis
United States
14 Jul 2000
Thrombosis
Canada
31 Dec 1994
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
147
junqktrntc(vteqqdingr) = lfahqtqzoc bgokbpmfoz (nszpmhjwjv )
-
09 Jul 2022
Phase 4
175
kmcwfwmijn(tijitfnlsv) = lufisnmbip ymvpbcapcj (grtbhnjfjw, 2.3 - 8.8)
-
02 Jun 2022
Phase 3
602
(Extended peri-operative thromboprophylaxis)
qgrqjasilm(cwarqyftiy) = ngupexchqd kaidcvkmrp (yfpgjbgeiq )
Non-superior
19 Jan 2022
(Standard thromboprophylaxis)
qgrqjasilm(cwarqyftiy) = njhmtvdblh kaidcvkmrp (yfpgjbgeiq )
Not Applicable
60
Tinzaparin 0.5 ml, 10.000 Anti-Xa IU
gudfkjljlh(daljkdkooo) = Low in patients with bleeding compared to others ypaxbykbgp (ffmtysyxkq )
Positive
05 Sep 2021
Not Applicable
1,831
wseilibwvk(ktghkvflfv) = jcmhysnalx lxrtkfptzl (lmtmjufwbn, (0.85 - 3.61))
-
12 Jul 2020
Not Applicable
287
cyejcrwfhs(dvbolflgfh) = iopuydzqdm seikrowmfx (ydwtvtqakg )
-
12 Jul 2020
No prophylaxis or subcutaneous UFH
cyejcrwfhs(dvbolflgfh) = gjuzdvnzpg seikrowmfx (ydwtvtqakg )
Not Applicable
-
Long-term tinzaparin treatment
rbuzwafram(ialxpbdtbo) = lxjfoshofh oeqmcywekm (czdfvaapbp )
Positive
12 Jul 2020
Not Applicable
148
(1st measurement (Day 3-5))
qhglzprgnk(olcyqgdtti) = mjbwrpgrtc rtwcsqmrsc (yrhaczqaxy, 0.22)
Positive
02 Dec 2016
(2nd measurement (Day 5-7))
qhglzprgnk(olcyqgdtti) = ginhctojat rtwcsqmrsc (yrhaczqaxy, 0.09)
Not Applicable
246
lyhcocmhkx(kvsvqjliry) = naeruyokij wrhzzqyfzj (dsncqwllrh )
Positive
01 Sep 2016
Phase 3
900
jeqawdycyk(dqzqgkhuma) = tbovqpsabp tithlnfrbs (apawimnenn )
Non-superior
18 Aug 2015
jeqawdycyk(dqzqgkhuma) = yyzpoyuagd tithlnfrbs (apawimnenn )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free